Secreted protein acidic and rich in cysteine (SPARC) can inhibit omental metastasis of ovarian cancer by inhibiting the interaction between ovarian cancer cells and adipocytes, thereby inhibiting the phenotypic plasticity of omental adipocytes and metabolic reprogramming [111]. Here, SPARC is linked to ovarian cancer.